The following information was accurate at the time of posting, but may be superseded by subsequent disclosure.
November 30, 2009
Tekmira to Webcast Presentation at the Piper Jaffray Health Care Conference
November 12, 2009
Tekmira Announces Third Quarter 2009 Operating Results and Provides Corporate Update
November 9, 2009
Tekmira Conference Call; Third Quarter 2009 Results and Corporate Update
September 8, 2009
Tekmira to Webcast Presentation at the Rodman & Renshaw Global Investment Conference
August 12, 2009
Tekmira Announces Second Quarter 2009 Operating Results
August 7, 2009
Tekmira Conference Call Advisory - Second Quarter 2009 Operating Results and Corporate Update
August 6, 2009
Alnylam and Tekmira Participate in New Research Collaboration
July 2, 2009
Tekmira Initiates ApoB SNALP Phase 1 Clinical Trial
May 28, 2009
Tekmira Presents ApoB SNALP and PLK1 SNALP Data at Leading Scientific Conference
May 13, 2009
Tekmira Announces First Quarter 2009 Operating Results and Provides Corporate Update
May 11, 2009
Roche Partners with Tekmira to Advance RNAi Product Candidates
May 11, 2009
Tekmira Conference Call Advisory - First Quarter 2009 Operating Results and Corporate Update
May 7, 2009
Tekmira Receives Clearance from FDA to Initiate ApoB SNALP Phase 1 Clinical Trial
April 14, 2009
Tekmira Pharmaceuticals Files IND for ApoB SNALP
April 3, 2009
Tekmira Partner Alnylam Initiates ALN-VSP Phase 1 Trial
March 25, 2009
Tekmira Extends Research Collaboration with Bristol-Myers Squibb through 2009
March 24, 2009
Tekmira Reports 2008 Audited Results and Provides Corporate Update
March 18, 2009
Tekmira Conference Call Advisory 2008 Audited Results and Corporate Update
February 24, 2009
Tekmira Presents Data Demonstrating Further Increases in SNALP Potency
February 23, 2009
Tekmira Publishes PLK1 SNALP Anti-Tumor Efficacy Data
February 12, 2009
Tekmira Partner Alnylam Presents Data at Keystone Meeting
January 23, 2009
Tekmira Partner Alnylam Receives Clearance from FDA to Initiate Clinical Trial Utilizing SNALP
January 8, 2009
Tekmira Announces $11.2 million 3-Year Manufacturing and Development Commitment from Partner Alnylam